Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) worldwide. Its pathogenesis encompasses functional alterations involving elevated intraglomerular and systemic pressure, increased activity of the renin-angiotensin system (RAS) and oxidative stress, and the eventual de...

Full description

Bibliographic Details
Main Authors: Rosaria Vincenza Giglio, Angelo Maria Patti, Ali Abbas Rizvi, Anca Panta Stoian, Marcello Ciaccio, Nikolaos Papanas, Andrej Janez, Alper Sonmez, Maciej Banach, Amirhossein Sahebkar, Manfredi Rizzo
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biomedicines
Subjects:
diabetes mellitus
kidney disease
innovative therapy
cardiovascular risk
kidney protection
Online Access:https://www.mdpi.com/2227-9059/11/2/291

Internet

https://www.mdpi.com/2227-9059/11/2/291

Similar Items